Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its price target raised by analysts at HC Wainwright from $4.00 to $7.50. They now have a "buy" rating on the stock.
Unicycive Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
Unicycive Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
Unicycive Therapeutics Announces Full Year 2024 Financial Results and Provides Business Update
DaVita Stock Declines 1.2% in 3 Months: Here's How to Play [Yahoo! Finance]